| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/24/2008 | US20080176848 e.g. N-Hydroxy-3-{1-[4-(1-methyl-1H-indol-5-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide; antiproliferative, anticarcinogenic, antiinflammatory, neuroleptic agent, autoimmune disorders |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/24/2008 | US20080176840 e.g. 4-(4-(6-(N-(2-methoxyethyl)-N-methylamino)pyridin-3-yl)-5-hydroxy-4H-1,2,4-triazol-3-yl)-6-isopropylbenzene-1,3-diol; Heat Shock Protein 90 (HSP90) modulator; antiproliferative, anticarcinogenic, antiinflammatory agent; angiogenesis inhibition, infections |
| 07/24/2008 | US20080176834 Quinolone Carboxylic Acids, Derivatives Thereof, and Methods of Making and Using Same |
| 07/24/2008 | US20080176831 e.g. 1-[4-chloro-6-(2,2,2-trifluoro-1-methylethylamino)-5-(2,4,6-trifluorophenyl)pyrimidin-2-yl]-pyrrolidin-2-one; controlling phytopathogenic harmful fungi, such as Ascomycetes, Deuteromycetes, Oomycetes and Basidiomycetes; materials, plants, soil, seeds; |
| 07/24/2008 | US20080176827 e.g. ethyl 6-(3-{2-[(benzylsulfonyl)amino]-2-oxoethyl}pyrrolidin-1-yl)-5-cyano-2-methylnicotinate; P2Y12 (G-protein coupled receptor) antagonist and anti-trombotic agent; high potency and selectivity; cardiovascular disorders, platelet aggregation disorder, acute thrombotic occlusion |
| 07/24/2008 | US20080176826 Pyridine Compounds For Combating Arthropod Pests and Nematodes |
| 07/24/2008 | CA2823905A1 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 07/24/2008 | CA2823883A1 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 07/24/2008 | CA2675676A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | CA2675419A1 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 07/24/2008 | CA2674946A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/23/2008 | EP1947100A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 07/23/2008 | EP1947099A1 Process for solvent removal from omeprazole salts |
| 07/23/2008 | EP1947098A1 Cyclic amine compounds and pest control agent |
| 07/23/2008 | EP1947091A1 Pyrimidyl nitrile derivatives as cysteine protease inhibitors |
| 07/23/2008 | EP1947086A1 Benzene derivative or salt thereof |
| 07/23/2008 | EP1946108A2 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 07/23/2008 | EP1945628A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/23/2008 | EP1945627A1 Pyrimidine derivatives for the treatment of cancer |
| 07/23/2008 | EP1945626A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 07/23/2008 | EP1945617A2 Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
| 07/23/2008 | EP1945616A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 07/23/2008 | EP1945613A1 Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of copd and asthma |
| 07/23/2008 | EP1945612A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 07/23/2008 | EP1945611A1 N- (hetero) aryl indole derivatives as pesticides |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1945219A2 Compound |
| 07/23/2008 | EP1945213A2 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1625119B1 Substituted-1-phthalazinamines as vr-1 antagonists |
| 07/23/2008 | EP1615909B1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 07/23/2008 | EP1567489B1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1315715B1 Quinazoline derivatives as kinase inhibitors |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | CN101228647A Monoamine compound, charge-transporting material, and organic electroluminescent device |
| 07/23/2008 | CN101228156A Fungicidal carboxamides |
| 07/23/2008 | CN101228152A N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/23/2008 | CN101228151A Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidine-2-ylamino)-benzamide |
| 07/23/2008 | CN101228150A Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 07/23/2008 | CN101228149A Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 07/23/2008 | CN101225601A Multifunctional reactive cotton ultraviolet absorbent, synthetic method and use thereof |
| 07/23/2008 | CN101225083A Tetrahydro quinazoline ketone compound and use thereof in preparation of medicine treating and preventing virus diseases |
| 07/23/2008 | CN101225070A Antineoplastic medicament |
| 07/23/2008 | CN100404530C Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 07/23/2008 | CN100404529C 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 07/23/2008 | CN100404528C Novel pyrimidineamide derivatives and the use thereof |
| 07/23/2008 | CN100404511C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 07/23/2008 | CN100404510C Enantioselective alkylation of tricyclic compounds |
| 07/23/2008 | CN100404509C Isoquinoline compound, preparation method and application of salt thereof |
| 07/23/2008 | CN100404508C Tetrahydroquinoline derivatives |
| 07/23/2008 | CN100404505C Novel substituted indoles |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | US7402676 Substituted dihydro 3-halo-1H-pyrazole-5-carboxylates their preparation and use |
| 07/22/2008 | US7402675 Process for the synthesis of amine ethers from secondary amino oxides |
| 07/22/2008 | US7402639 Narrow moleculae weight distribution; addition piolymers; process control |
| 07/22/2008 | US7402606 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402592 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
| 07/22/2008 | US7402589 such as 1-(4-Fluorophenyl)-1-{2-[(1S)-2-hydroxy-1,2-dimethyl-propylamino]-pyrimidin-4-yl}-3-o-tolyl-urea; Interleukin-1, Cycloxygenase-2, Tumor Necrosis Factor- alpha antagonist; antiinflammatory agent; rheumatoid arthritis or osteoarthritis |
| 07/22/2008 | US7402587 Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists |
| 07/22/2008 | US7402586 3-Benzylsulfonylamino-6-methyl-1-[(3-guanidinooxypropyl)aminocarbonylmethyl]-2-pyridinone trifluoroacetate; anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 07/22/2008 | US7402585 For example, 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-phenylacetamide; use in the treatment of certain diseases, in particular to proliferative disease such as cancer |
| 07/22/2008 | US7402583 Substituted quinolines as antitumor agents |
| 07/22/2008 | US7402581 3,5-Dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide; neurokinin 1 and 2 (NK1,2) receptors, antagonist; improved pharmacokinetics: not inhibit liver enzyme cytochrome P450, prevent drug-drug interactions, oral bioavailability, antiinflammatory and analgesic |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/22/2008 | CA2278223C 1,4-dihydropyridin derivatives and their use in therapy |
| 07/22/2008 | CA2238171C Quinoline derivatives as nk3 antagonists |
| 07/17/2008 | WO2008086462A2 AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS |
| 07/17/2008 | WO2008086404A1 5-pyridinone substituted indazoles |
| 07/17/2008 | WO2008086128A2 Aminopyrazole kinase inhibitors |
| 07/17/2008 | WO2008086014A2 Bis-aryl amide derivatives useful for the treatment of cancer |
| 07/17/2008 | WO2008085316A1 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 07/17/2008 | WO2008085119A1 New pyridine analogues viii 518 |
| 07/17/2008 | WO2008085118A1 Pyridine compounds and their use as p2y12 antagonists. |
| 07/17/2008 | WO2008085117A1 Pyridine compounds and their use as p2y12 antagonists. |
| 07/17/2008 | WO2008085008A1 T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
| 07/17/2008 | WO2008084300A1 Inhibitors of serine palmitoyltransferase |
| 07/17/2008 | WO2008084299A1 Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1h-pyrazol-3-yl) phenoxy)methyl)quinoline |
| 07/17/2008 | WO2008084261A1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| 07/17/2008 | WO2008084223A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084073A1 Heteroaryl-substituted serine amides |
| 07/17/2008 | WO2008084004A1 Sulfonamide derivatives as chymase inhibitors |
| 07/17/2008 | WO2008083491A1 Compounds and method for treatment of cancer |
| 07/17/2008 | WO2008067219A3 Quinazolinone modulators of tgr5 |
| 07/17/2008 | WO2008063625A3 Pyridine compounds and methods of their use |
| 07/17/2008 | WO2008056257A3 Novel triazinedione derivatives as gaba-b receptor modulators |
| 07/17/2008 | WO2008050101A3 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk |
| 07/17/2008 | WO2008045564A8 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 07/17/2008 | WO2008042282B1 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 07/17/2008 | WO2008030584A3 Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171879 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 07/17/2008 | US20080171874 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/17/2008 | US20080171873 Converting a chiral epoxyester or epoxycarboxamide to a chiral primary epoxyamine with an alkali hypohalite; reducing to form the amine;2-benzyl-4-methyl-4-phenyl-(1-oxo-1,3-dihydroisobenzofuran-5-yl)amino-pentan-2-ol; 4-methyl-2,4-diphenyl-(1-oxo-1,3-dihydroisobenzofuran-5-yl)amino-pentan-2-ol |